中东和非洲肠外营养市场预测至 2030 年 - 区域分析 - 按营养类型（单剂量氨基酸溶液、肠外脂质乳剂、碳水化合物、微量元素、维生素和矿物质）和最终用户（医院、诊所等）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

No. of Pages: 84    |    Report Code: BMIRE00030469    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Parenteral Nutrition Market
Free Sample Buy Now
2022 年中东和非洲肠外营养市场价值为 2.0888 亿美元，预计到 2030 年将达到 2.889 亿美元；预计 2022 年至 2030 年的复合年增长率为 4.1%。

营养产品配方创新促进中东和非洲肠外营养市场发展

对帮助消费者主动管理健康的产品的需求激增，尤其是那些专注于能量水平、免疫力和疾病治疗方面的特定需求的产品。营养需求因疾病类型而异。肠外产品的功能和特定配方不会干扰现有的治疗，并有助于根据要求提供更精确和增强的治疗。肠外营养的常量营养素和微量营养素配方及其应用因疾病类型而异，包括癌症和胃肠道疾病。

创新配方的重大发展带来了营养解决方案的新时代，这些解决方案旨在满足所有个人需求以及每位患者的医疗状况。这种个性化程度除了提高肠外营养的有效性外，还改善了患者的治疗效果。配方创新使市场能够充分满足不同患者的独特营养需求，从新生儿和老年人到患有某些疾病的人。例如，具有改进的稳定性和生物利用度的脂质乳剂的出现正在改变静脉营养的面貌，特别是用于治疗早产儿。此外，由于这些配方创新，传统上与传统营养解决方案相关的问题和副作用的固有风险也降低了。由于该行业具有促进医疗保健生态系统中肠外营养的采用和改善患者护理的双重好处，因此该行业有望实现卓越的增长和长期成功。因此，营养产品配方的创新预计将在预测期内为市场增长创造机会。因此，营养产品配方的创新是肠外医学营养市场未来的增长趋势。

中东和非洲肠外营养市场概览

根据沙特阿拉伯统计总局 2020 年中期的一份报告，沙特阿拉伯每年约有 25,000 名婴儿早产。早产儿被放在保温箱中 30-60 天，政府医院或保险公司可能需要花费约 16,000 美元（60,000 沙特里亚尔）进行个人治疗和专门护理。如果需要将婴儿放在保温箱中更长时间，则费用可能约为 26,667 美元（100,000 沙特里亚尔）。在这种情况下，营养支持对于获得与同龄婴儿相似的生长速度至关重要，可以通过肠内或肠外方式提供。大多数未成熟的早产儿依赖肠外营养，尤其是出生体重低（<1,500 克）的婴儿。由于早产相关的严重医疗问题（如主要器官发育不全、感染和喂养不耐受），此类婴儿无法获得肠内喂养。该国卫生部 (MoH) 运营着 287 家医院。根据卫生部公布的数据，目前有 236 家医院提供家庭医疗保健，其中一些医院提供家庭肠内营养 (HEN) 或家庭肠外营养 (HPN)，或两者兼有。因此，由于早产数量的增加以及政府加大力度支持和提高民众对肠外营养的认识，预计沙特阿拉伯对肠外营养的需求将迅速增长。

中东和非洲肠外营养市场收入及预测至 2030 年（百万美元）

中东和非洲肠外营养市场细分

中东和非洲肠外营养市场根据营养类型、最终用户和国家/地区进行细分。根据营养类型，中东和非洲肠外营养市场分为单剂量氨基酸溶液、肠外脂质乳剂、碳水化合物、微量元素以及维生素和矿物质。单剂量氨基酸溶液部分在 2022 年占据最大市场份额。

按最终用户划分，中东和非洲肠外营养市场分为医院、诊所和其他。医院部分在 2022 年占据最大市场份额。

根据国家/地区，中东和非洲肠外营养市场分为沙特阿拉伯、南非、阿联酋和中东及非洲其他地区。 2022 年，沙特阿拉伯占据了中东和非洲肠外营养市场的主导份额。

ICU Medical Inc、Grifols SA、辉瑞公司、大冢制药有限公司、百特国际公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd 和 Vifor Pharma Management AG 是中东和非洲肠外营养市场的一些领先参与者。

Middle East & Africa Parenteral Nutrition Strategic Insights

Strategic insights for Middle East & Africa Parenteral Nutrition involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-parenteral-nutrition-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Parenteral Nutrition Report Scope

Report Attribute Details
Market size in 2022 US$ 208.88 Million
Market Size by 2030 US$ 288.90 Million
Global CAGR (2022 - 2030) 4.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 营养成分类型
  • 单剂量氨基酸溶液
  • 肠外脂肪乳剂
  • 碳水化合物
  • 微量元素
  • 维生素和矿物质
By 最终用户
  • 医院
  • 诊所
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Aculife Healthcare Pvt Ltd
  • Vifor Pharma Management AG
    		•
    Get more information on this report

    Middle East & Africa Parenteral Nutrition Regional Insights

    The regional scope of Middle East & Africa Parenteral Nutrition refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-parenteral-nutrition-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Middle East & Africa Parenteral Nutrition Market

    1. ICU Medical Inc
    2. Grifols SA
    3. Pfizer Inc
    4. Otsuka Pharmaceuticals Co Ltd
    5. Baxter International Inc
    6. B Braun SE
    7. Fresenius Kabi AG
    8. Aculife Healthcare Pvt Ltd 
    9. Vifor Pharma Management AG

    Frequently Asked Questions
    How big is the Middle East & Africa Parenteral Nutrition Market?

    The Middle East & Africa Parenteral Nutrition Market is valued at US$ 208.88 Million in 2022, it is projected to reach US$ 288.90 Million by 2030.

    What is the CAGR for Middle East & Africa Parenteral Nutrition Market by (2022 - 2030)?

    As per our report Middle East & Africa Parenteral Nutrition Market, the market size is valued at US$ 208.88 Million in 2022, projecting it to reach US$ 288.90 Million by 2030. This translates to a CAGR of approximately 4.1% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Parenteral Nutrition Market report typically cover these key segments-

  • 营养成分类型 (单剂量氨基酸溶液, 肠外脂肪乳剂, 碳水化合物, 微量元素, 维生素和矿物质)
  • 最终用户 (医院, 诊所)

    • What is the historic period, base year, and forecast period taken for Middle East & Africa Parenteral Nutrition Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Parenteral Nutrition Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
    • Who are the major players in Middle East & Africa Parenteral Nutrition Market?

    The Middle East & Africa Parenteral Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Aculife Healthcare Pvt Ltd
  • Vifor Pharma Management AG
    • Who should buy this report?

    The Middle East & Africa Parenteral Nutrition Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Parenteral Nutrition Market value chain can benefit from the information contained in a comprehensive market report.

    middle-east-and-africa-parenteral-nutrition-market